Behfar Ehdaie

5.9k total citations · 2 hit papers
123 papers, 3.1k citations indexed

About

Behfar Ehdaie is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Behfar Ehdaie has authored 123 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pulmonary and Respiratory Medicine, 44 papers in Surgery and 19 papers in Urology. Recurrent topics in Behfar Ehdaie's work include Prostate Cancer Diagnosis and Treatment (71 papers), Prostate Cancer Treatment and Research (54 papers) and Bladder and Urothelial Cancer Treatments (30 papers). Behfar Ehdaie is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (71 papers), Prostate Cancer Treatment and Research (54 papers) and Bladder and Urothelial Cancer Treatments (30 papers). Behfar Ehdaie collaborates with scholars based in United States, Sweden and Canada. Behfar Ehdaie's co-authors include Andrew J. Vickers, James A. Eastham, Daniel D. Sjoberg, Peter T. Scardino, Mark Emberton, Hashim U. Ahmed, Karim Touijer, Massimo Valério, Ardeshir R. Rastinehad and Boris Hadaschik and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Behfar Ehdaie

117 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review

2014 345 citations Massimo Valério, Mark Emberton et al. European Urology profile →
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

2015 259 citations Debra A. Goldman, Behfar Ehdaie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Behfar Ehdaie United States	30	2.1k	1.0k	601	498	465	123	3.1k
Marc A. Bjurlin United States	33	2.3k 1.1×	1.4k 1.3×	645 1.1×	614 1.2×	472 1.0×	189	4.0k
Guillaume Ploussard France	31	2.3k 1.1×	1.0k 1.0×	616 1.0×	441 0.9×	473 1.0×	205	3.2k
Christopher Morash Canada	30	1.6k 0.8×	776 0.7×	520 0.9×	346 0.7×	211 0.5×	143	2.4k
Paolo Dell’Oglio Italy	35	2.7k 1.3×	1.6k 1.5×	826 1.4×	428 0.9×	570 1.2×	231	4.0k
Benjamin Pradère France	29	1.9k 0.9×	1.4k 1.4×	381 0.6×	303 0.6×	736 1.6×	310	3.5k
Kimmo Taari Finland	31	2.4k 1.1×	736 0.7×	510 0.8×	395 0.8×	776 1.7×	162	3.7k
Jeffrey S. Montgomery United States	30	1.5k 0.7×	1.5k 1.4×	381 0.6×	229 0.5×	436 0.9×	158	3.1k
M. Roumiguié France	25	1.2k 0.6×	1.3k 1.2×	355 0.6×	234 0.5×	431 0.9×	199	2.5k
Erin Kirkby United States	16	1.6k 0.8×	631 0.6×	414 0.7×	266 0.5×	342 0.7×	24	2.4k
Patricia Landis United States	31	3.8k 1.8×	1.2k 1.1×	697 1.2×	284 0.6×	636 1.4×	71	4.3k

Countries citing papers authored by Behfar Ehdaie

Since Specialization

Citations

This map shows the geographic impact of Behfar Ehdaie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behfar Ehdaie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behfar Ehdaie more than expected).

Fields of papers citing papers by Behfar Ehdaie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behfar Ehdaie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behfar Ehdaie. The network helps show where Behfar Ehdaie may publish in the future.

Co-authorship network of co-authors of Behfar Ehdaie

This figure shows the co-authorship network connecting the top 25 collaborators of Behfar Ehdaie. A scholar is included among the top collaborators of Behfar Ehdaie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behfar Ehdaie. Behfar Ehdaie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fainberg, Jonathan, Taehyoung Lee, Emily Vertosick, et al.. (2024). Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic Efficacy. Urology Practice. 11(6). 983–990.

Gaffney, Christopher, Emily Vertosick, Vincent P. Laudone, et al.. (2024). Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical Prostatectomy. The Journal of Urology. 212(3). 401–408. 1 indexed citations

Carlsson, Sigrid, Mark A. Preston, Andrew J. Vickers, et al.. (2024). A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study. Applied Clinical Informatics. 15(2). 274–281. 1 indexed citations

Hu, Jim C., Andrew J. Vickers, Mohamad E. Allaf, et al.. (2023). Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications. BMJ Open. 13(5). e071191–e071191. 2 indexed citations

Lynch, Kathleen, et al.. (2023). Patient Perceptions of a Decision Support Tool for Men with Localized Prostate Cancer. MDM Policy & Practice. 8(1). 107903179–107903179. 1 indexed citations

Gaffney, Christopher, Amy L. Tin, Jonathan Fainberg, et al.. (2023). The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy. Cancer. 129(23). 3790–3796. 6 indexed citations

Ehdaie, Behfar, et al.. (2022). Comparison of US Cancer Center Recommendations for Prostate Cancer Screening With Evidence-Based Guidelines. JAMA Internal Medicine. 182(5). 555–555. 4 indexed citations

Bensley, Jonathan G., Behfar Ehdaie, Sigrid Carlsson, et al.. (2022). Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review. European Urology Oncology. 6(1). 4–15. 3 indexed citations

Zeléfsky, Michael J., Debra A. Goldman, Sean M. McBride, et al.. (2021). Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. Radiotherapy and Oncology. 159. 33–38. 20 indexed citations

10.

Vertosick, Emily, Spyridon P. Basourakos, James A. Eastham, et al.. (2021). Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms. European Urology Open Science. 30. 13–15. 6 indexed citations

11.

Truong, Hong, Kelsey Breen, Yelena Kemel, et al.. (2021). Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.. Journal of Clinical Oncology. 39(15_suppl). 5022–5022.

12.

Tracy, Chad R., et al.. (2020). Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores. Urologic Oncology Seminars and Original Investigations. 39(3). 193.e1–193.e6. 16 indexed citations

13.

Groß, Michael, Art Sedrakyan, Fernando J. Bianco, et al.. (2019). SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer. The Journal of Urology. 202(5). 952–958. 4 indexed citations

14.

Assel, Melissa, Daniel D. Sjoberg, Andrew J. Vickers, et al.. (2018). Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer. The Journal of Urology. 201(1). 77–83. 29 indexed citations

15.

Thong, Alan, Bing Ying Poon, Emily Vertosick, et al.. (2017). Concordance between patient-reported and physician-reported sexual function after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 36(2). 80.e1–80.e6. 3 indexed citations

16.

Gild, Philipp, Behfar Ehdaie, & Luis A. Kluth. (2017). Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival. Current Opinion in Urology. 27(5). 409–414. 27 indexed citations

17.

Valério, Massimo, Mark Emberton, Éric Barret, et al.. (2014). Health technology assessment in evolution – focal therapy in localised prostate cancer. Expert Review of Anticancer Therapy. 14(11). 1359–1367. 7 indexed citations

18.

Ehdaie, Behfar & Peter T. Scardino. (2014). A decade of progress in detection and treatment. Nature Reviews Urology. 11(11). 618–620. 1 indexed citations

19.

Rink, Michael, Évanguelos Xylinas, Vitaly Margulis, et al.. (2012). Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy. European Urology. 63(6). 1082–1090. 86 indexed citations

20.

Theodorescu, Dan & Behfar Ehdaie. (2008). Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis. Indian Journal of Urology. 24(1). 61–61. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact